SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (29)3/3/1998 1:48:00 PM
From: aknahow  Read Replies (1) | Respond to of 415
 
Thanks, I agree it's standard practice. Your information helps but, I still hate the practice because it's it's difficult enough to know if the science will work, how big the market is, what share they will capture and then not know what percent of sales they will earn. Speaking in general terms, re all cos. not just MCDE. Your 6-10% concept seems to make sense.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News